A human recombinant haemoglobin designed for use as a blood substitute
about
Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsionsBlood substitutes. Haemoglobin therapeutics in clinical practice.Investigation on artificial blood or substitute blood replace the natural bloodDevelopment of recombinant hemoglobin-based oxygen carriersA recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporterHb-based oxygen carriers: are we there yet?Artificial oxygen carriers as red blood cell substitutes: a selected review and current statusDissecting the role of protein-protein and protein-nucleic acid interactions in MS2 bacteriophage stability.WAXS studies of the structural diversity of hemoglobin in solution.Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2Hemoglobin conjugated with a Band 3 N-terminus derived peptide as an oxygen carrier.Haemoglobin-based oxygen carriers: research and reality towards an alternative to blood transfusions.Incorporation of norvaline at leucine positions in recombinant human hemoglobin expressed in Escherichia coli.Haemoglobin-based oxygen carriers.Blood substitutes: refocusing an elusive goal.Progress in the development of RBC substitutes.Hemoglobin based oxygen carriers: how much methemoglobin is too much?Enzymatic strategies and biocatalysts for amide bond formation: tricks of the trade outside of the ribosome.Protein engineering 20 years on.Current status of blood substitute research: towards a new paradigm.High-efficiency synthesis of human alpha-endorphin and magainin in the erythrocytes of transgenic mice: a production system for therapeutic peptides.Recombinant protein sequences can trigger methylation of N-terminal amino acids in Escherichia coli.Pericellular oxygen concentration of cultured primary human trophoblasts.Control of the allosteric equilibrium of hemoglobin by cross-linking agents.Application of high-precision isotope ratio monitoring mass spectrometry to identify the biosynthetic origins of proteinsToward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.Examining and mitigating acellular hemoglobin vasoactivity.Autoxidation and oxygen binding properties of recombinant hemoglobins with substitutions at the αVal-62 or βVal-67 position of the distal heme pocketInterfacial and distal-heme pocket mutations exhibit additive effects on the structure and function of hemoglobin.Analysis of human alpha globin gene mutations that impair binding to the alpha hemoglobin stabilizing proteinCoexpression of human alpha- and circularly permuted beta-globins yields a hemoglobin with normal R state but modified T state propertiesEngineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers.Exploring Oxidative Reactions in Hemoglobin Variants Using Mass Spectrometry: Lessons for Engineering Oxidatively Stable Oxygen Therapeutics.Bio-inspired nanomedicine strategies for artificial blood components.A mutation that improves soluble recombinant hemoglobin accumulation in Escherichia coli in heme excess.High-fidelity translation of recombinant human hemoglobin in Escherichia coli.Stabilization of apoglobin by low temperature increases yield of soluble recombinant hemoglobin in Escherichia coli.Monodisperse 130 kDa and 260 kDa Recombinant Human Hemoglobin Polymers as Scaffolds for Protein Engineering of Hemoglobin-Based Oxygen Carriers.Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.
P2860
Q24795325-CFC3B711-DE40-4B71-B09D-4B5964A8E191Q24795346-C4C9F1D9-24F2-429F-A120-DCA76BB0159DQ26830894-C83FA7AC-5024-4B6B-96A7-D07D1291BF99Q27008891-7947BCE8-3CA6-425C-8EFF-67F6BDB457C0Q28190278-BD27C5F2-380D-4DD6-8A47-F71F63C908F4Q28206212-3195C642-9785-48BC-A9E8-EBF49FD9DBDFQ28277962-3211D7ED-6E31-42CD-A8ED-DC7C1FEA144CQ30354317-F42C2B50-DD1F-4034-8BEB-9439268BD48DQ30400961-4D0F7BA8-C962-4E9F-96D3-0EB799270F18Q33338311-51AE84C6-0C35-49D2-AD64-832685E724DCQ33398580-62443CA4-5F99-4522-B7AC-BE001D1EF534Q33962451-76DC3DC6-6C63-4061-A509-E8CE17D0E6D2Q34065445-70740150-1946-46DB-B468-0270DCEEC92CQ34075036-E3924FE0-700A-4D04-9C44-25F3D7F63DF9Q34106855-E905B552-C10B-484E-9B73-D34923F2B18EQ34175158-E27EB594-9FEC-4AE0-80CC-969D18873779Q34465887-6EC2801D-09D1-45CC-9314-E44C5B2E2B2BQ35006444-8D93F89A-1CDB-41A1-B67A-1FA1065BBFE3Q35014053-9F4CCF2D-B45D-4FE5-965C-6EA8F47F73CFQ35110088-93BA67F3-5041-4C34-BCAD-0D7119569570Q35781346-A503F1DF-CA95-4ABA-AD7C-C2A7BBC6DF7AQ36278996-C0AF3BA8-049C-42E8-8AD3-CFC5DA75C0E1Q36585669-B6D5401B-9048-4B13-9DB1-8B9133863B76Q36639420-C235B295-F6E5-4804-B2A7-F31518802E4AQ36640547-F9302B72-7D8E-41AF-9E8B-7F6DACFA275CQ36647460-F8ADBCD7-3B45-44A1-9311-FBBA3E569A5CQ36801603-68255776-3ED5-4F63-A0EF-C23CB37D095FQ37132170-21B5445D-B153-47DA-953F-9061F639E751Q37217030-26FA4124-F889-4D1A-AC00-24753518EAEBQ37237484-1200DF34-DD14-414D-8E7A-A4F8C801589CQ37301645-F5A8CE52-6D42-45CF-849B-4BD069241A80Q37394306-6AFADA62-9953-40FB-A6DA-9D7CF7DA414FQ37727980-4080A24E-8553-4C1C-96C1-8F08BD55C354Q38809485-A77375D4-6B20-4AA5-B45F-A9251D62DF35Q39179984-9A3D0A7A-2EBE-45EE-B0C9-09ECA6EAAAADQ39480431-50BDD568-8743-457C-AD3F-03446412EEB4Q39560497-08012054-3443-4E98-B9C9-6A70EC5E493BQ39803392-1608FC22-3535-41C1-84F2-49FEA76E5FBCQ39873198-6A4C8851-E440-4DE5-B169-486313D31932Q40082240-ECCC6ADD-9C7D-479D-926B-2483F6A74FE3
P2860
A human recombinant haemoglobin designed for use as a blood substitute
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A human recombinant haemoglobin designed for use as a blood substitute
@ast
A human recombinant haemoglobin designed for use as a blood substitute
@en
A human recombinant haemoglobin designed for use as a blood substitute
@en-gb
A human recombinant haemoglobin designed for use as a blood substitute
@nl
type
label
A human recombinant haemoglobin designed for use as a blood substitute
@ast
A human recombinant haemoglobin designed for use as a blood substitute
@en
A human recombinant haemoglobin designed for use as a blood substitute
@en-gb
A human recombinant haemoglobin designed for use as a blood substitute
@nl
prefLabel
A human recombinant haemoglobin designed for use as a blood substitute
@ast
A human recombinant haemoglobin designed for use as a blood substitute
@en
A human recombinant haemoglobin designed for use as a blood substitute
@en-gb
A human recombinant haemoglobin designed for use as a blood substitute
@nl
P2093
P3181
P356
P1433
P1476
A human recombinant haemoglobin designed for use as a blood substitute
@en
P2093
A J Mathews
D Abbott-Brown
J Miller-Roehrich
S Shoemaker
P2888
P304
P3181
P356
10.1038/356258A0
P407
P577
1992-03-19T00:00:00Z
P6179
1048837652